Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Buttrick

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Circulation|January 5, 2026
Myocardial Recovery With Mechanical Circulatory Support Is Linked to Alternative Splicing and Subcellular Localization of CAMK2DThomas G Martin, Dakota R Hunt, Christopher C Ebmeier, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Cytoplasmic CaMKIIδ-B prevents myocardial recovery in heart failureThomas G Martin, Dakota R Hunt, Christopher C Ebmeier, et al.
Circulation|July 21, 2022
Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the HeartYuanbiao Zhao, Andrew S Riching, Walter E Knight, et al.
Circulation Research|January 28, 2012
Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanismMaria A Cavasin, Kim Demos-Davies, Todd R Horn, et al.
American Heart Journal|September 1, 2020
An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trialGrace E Venechuk, Prateeti Khazanie, Robert L Page, et al.
Circulation|November 17, 2020
An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF TrialLarry A Allen, Grace Venechuk, Colleen K McIlvennan, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 24, 2023
Functional and molecular determinants of right ventricular response to severe pulmonary hypertension in a large animal modelR Dale Brown, Kendall S Hunter, Min Li, et al.
Circulation. Heart Failure|March 7, 2025
Heart Rate Reduction Is Associated With Reverse Left Ventricular Remodeling and Mechanism-Specific Molecular Phenotypes in Dilated CardiomyopathyNatasha L Altman, Edward A Gill, Rami Kahwash, et al.
Stem Cell Reports|February 26, 2021
Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic CardiomyopathyWalter E Knight, Yingqiong Cao, Ying-Hsi Lin, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Circulation|January 5, 2026
Myocardial Recovery With Mechanical Circulatory Support Is Linked to Alternative Splicing and Subcellular Localization of CAMK2DThomas G Martin, Dakota R Hunt, Christopher C Ebmeier, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Cytoplasmic CaMKIIδ-B prevents myocardial recovery in heart failureThomas G Martin, Dakota R Hunt, Christopher C Ebmeier, et al.
Circulation|July 21, 2022
Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the HeartYuanbiao Zhao, Andrew S Riching, Walter E Knight, et al.
Circulation Research|January 28, 2012
Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanismMaria A Cavasin, Kim Demos-Davies, Todd R Horn, et al.
American Heart Journal|September 1, 2020
An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trialGrace E Venechuk, Prateeti Khazanie, Robert L Page, et al.
Circulation|November 17, 2020
An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF TrialLarry A Allen, Grace Venechuk, Colleen K McIlvennan, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 24, 2023
Functional and molecular determinants of right ventricular response to severe pulmonary hypertension in a large animal modelR Dale Brown, Kendall S Hunter, Min Li, et al.
Circulation. Heart Failure|March 7, 2025
Heart Rate Reduction Is Associated With Reverse Left Ventricular Remodeling and Mechanism-Specific Molecular Phenotypes in Dilated CardiomyopathyNatasha L Altman, Edward A Gill, Rami Kahwash, et al.
Stem Cell Reports|February 26, 2021
Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic CardiomyopathyWalter E Knight, Yingqiong Cao, Ying-Hsi Lin, et al.
Pageof 6